Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,761 | 99,652 | 75,364 | 55,696 | 20,547 |
| Depreciation Amortization | 598 | -3,213 | 1,408 | 931 | 462 |
| Income taxes - deferred | -13,110 | -37,537 | -22,355 | -31,469 | -13,705 |
| Accounts receivable | 20,714 | -5,810 | -15,653 | -10,591 | -7,843 |
| Accounts payable and accrued liabilities | -7,644 | 25,068 | 19,070 | 8,149 | 12,571 |
| Other Working Capital | 5,294 | -1,406 | -10,591 | -13,939 | -22,671 |
| Other Operating Activity | 9,137 | 65,242 | 56,305 | 40,290 | 15,409 |
| Operating Cash Flow | $-16,772 | $141,996 | $103,548 | $49,067 | $4,770 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,743 | -319,607 | 81,762 | 67,117 | -3,067 |
| PPE Investments | -201 | -211 | -161 | -161 | -104 |
| Purchase Of Investment | N/A | 389,576 | N/A | N/A | N/A |
| Investing Cash Flow | $4,542 | $69,758 | $81,601 | $66,956 | $-3,171 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,521 | 25,490 | 20,168 | 15,965 | 3,455 |
| Common Stock Repurchased | N/A | -172,915 | -172,915 | -130,451 | -27,433 |
| Other Financing Activity | -5,761 | -72,941 | -36,403 | -28,251 | -15,825 |
| Financing Cash Flow | $760 | $-220,366 | $-189,150 | $-142,737 | $-39,803 |
| Exchange Rate Effect | -287 | 1,442 | 1,474 | 1,794 | 358 |
| Beginning Cash Position | 121,745 | 127,665 | 127,665 | 127,665 | 128,665 |
| End Cash Position | 109,988 | 120,495 | 125,138 | 102,745 | 90,819 |
| Net Cash Flow | $-11,757 | $-7,170 | $-2,527 | $-24,920 | $-37,846 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,772 | 141,996 | 103,548 | 49,067 | 4,770 |
| Capital Expenditure | -201 | -211 | -161 | -161 | -104 |
| Free Cash Flow | -16,973 | 141,785 | 103,387 | 48,906 | 4,666 |